[Use of low-molecular-weight heparins in patients with prosthetic heart valves].
Herz- und Diabeteszentrum Nordrhein-Westfalen, Kardiologische Klinik, Universitätsklinik der Ruhr-Universität Bochum, Bad Oeynhausen. akohlstaedt@hdz-nrw.de
D
D
Hering
D
D
Horstkotte
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D004617:Embolism / Q000209:etiology / Q000517:prevention & control*; D006350:Heart Valve Prosthesis / Q000009:adverse effects; D006470:Hemorrhage / Q000209:etiology / Q000517:prevention & control*; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D012307:Risk Factors; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control*
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight